ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool
Trince at ELRIG Drug Discovery 2026
Oct 14–15, 2026 London, UK ~3k attendees Website
Trince takes part in 1 session at ELRIG Drug Discovery 2026 in London, and exhibits at Booth J20. Its program centres on CRISPR-Cas9 gene editing in adherent cell models. It covers photoporation, which allows that editing to run in plates with spatial control.
| Organization | ELRIG Drug Discovery 2026 Attendance |
|---|---|
Trince Ghent, Belgium | |
Ghent University spin-off making LumiPore, a laser photoporation platform that delivers molecules into hard-to-transfect adherent and suspension cells. | Booth Exhibiting at Booth J20 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 4:15pm–4:30pm Photoporation Enables Plate-Based and Spatially Controlled CRISPR-Cas9 Gene Editing in Adherent Cell Models Using laser-activated nanoparticles to open cell membranes briefly so CRISPR editing tools enter cells growing in ordinary assay plates, even in chosen areas. |
Instantly find 20 buyers from Trince
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by ELRIG. Submit a correction